Clinical Features and Outcomes of CDK4/6 Inhibitor Therapy vs Chemotherapy in Patients With HR+/HER2− Advanced Breast Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The Oncologist
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
CDK4/6-Inhibitors Versus Chemotherapy in Advanced HR+/HER2-Negative Breast Cancer: Results and Correlative Biomarker Analyses of the KENDO Randomized Phase II Trial
Oncologist 2024 Jan 04;[EPub Ahead of Print], F Schettini, M Palleschi, F Mannozzi, F Brasó-Maristany, L Cecconetto, P Galván, M Mariotti, A Ferrari, E Scarpi, A Miserocchi, O Nanni, E Sanfeliu, A Prat, A Rocca, U De GiorgiFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.